• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

SoftOx Solutions

Less than 1K followers

SOFTX

Euronext Growth Oslo

Biotechnology & Pharmaceuticals

Health Care

Overview
Investor consensus

SoftOx Solutions is a Norwegian medical technology company. The company has developed a proprietary solution based on acetic acid for the treatment of chronic wounds in patients. The solution is used to eliminate infections associated with biofilms, which consist of different clusters of bacteria. Part of the drug development is done in collaboration with other research institutes. SoftOx Solutions was founded in 2012 and is headquartered in Oslo, Norway.

Read more
Market cap
-
Turnover
-
Revenue
15.58M
EBIT %
-72.97 %
P/E
-
Dividend yield-%
-
Financial calendar
23/6
2026

General meeting '26

24/6
2026

Interim report Q1'26

23/9
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Regulatory press release19 hours ago

SoftOx Solutions AS: FIRST PARTICIPANT ENROLLED IN BIODEFENCE-FOCUSED SIS-02 PHASE 1 CLINICAL STUDY

SoftOx Solutions
Regulatory press release5/27/2026, 6:00 AM

SoftOx Solutions AS: Annual Report 2025

SoftOx Solutions
Press release5/12/2026, 1:37 PM

Analyst Group: Analyst Group intervjuar SoftOx Solutions styrelseordförande Ulrik Spork

SoftOx Solutions

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/21/2026, 11:44 AM

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release4/13/2026, 6:31 AM

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release3/25/2026, 7:00 AM

SoftOx Solutions AS: Fourth Quarter Report 2025

SoftOx Solutions
Regulatory press release3/24/2026, 8:36 PM

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release3/11/2026, 9:00 AM

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release3/3/2026, 7:24 AM

SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03)

SoftOx Solutions
Regulatory press release2/25/2026, 7:00 AM

SoftOx Defense Solutions AS: HPRA Approves SIS-02 Phase 1 Trial, Strengthening Dual-Use and Preparedness Strategy

SoftOx Solutions
Regulatory press release2/4/2026, 11:43 AM

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release1/23/2026, 1:36 PM

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release12/29/2025, 8:33 AM

SoftOx Solutions AS: Danish Medicines Agency Approves Phase 2a Trial for SoftOx Inhalation Solution

SoftOx Solutions
Regulatory press release12/18/2025, 4:05 PM

SOFTX: Financial calendar

SoftOx Solutions
Regulatory press release12/15/2025, 9:23 AM

SoftOx Solutions AS: Minutes from the Extraordinary General Meeting

SoftOx Solutions
Regulatory press release12/5/2025, 5:11 PM

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release11/28/2025, 1:32 PM

SoftOx Solutions AS: Notice of Extraordinary General Assembly

SoftOx Solutions
Regulatory press release11/28/2025, 1:31 PM

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release11/26/2025, 7:00 AM

SoftOx Solutions AS: Third Quarter Report 2025

SoftOx Solutions
Regulatory press release11/14/2025, 7:35 AM

SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured - Key Milestone for CF and EDF Clinical Programs

SoftOx Solutions